FFAGLDD (TFA)
FFAGLDD TFA is MMP9 selective cleavage peptides, which used for cytosolic delivery of Doxorubi-cin (DOX) and achieve temporally and spatially controlled slow drug delivery and release[1].
Product Specifications
UNSPSC
12352209
Target
MMP
Type
Peptides
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ffagldd-tfa.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](C)C(NCC(N[C@@H](CC(C)C)C(N[C@@H](CC(O)=O)C(N[C@@H](CC(O)=O)C(O)=O)=O)=O)=O)=O)=O)[C@H](CC2=CC=CC=C2)N.OC(C(F)(F)F)=O
Molecular Formula
C39H50F3N7O14
Molecular Weight
897.85
References & Citations
[1]Zhou Q, et al. Stimuli-responsive polymeric micelles for drug delivery and cancer therapy. Int J Nanomedicine. 2018 May 18;13:2921-2942.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
MMP-9
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
544513-01 10 µg
Secretory Phospholipase A2 Receptor 1 (PLA2R1), Recombinant, Human, aa21-663, His-Tag
Ask
View Details 544513-02 50 µg
Secretory Phospholipase A2 Receptor 1 (PLA2R1), Recombinant, Human, aa21-663, His-Tag
Ask
View Details 
